Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

PCI前肾功能评估的方法选择很重要

L.A. McKeown

June 29, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

Presentation

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Presenter: J. Parsh

June 26, 2015

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

Renal Denervation Shows Sustained BP Improvements at 1 Year

Jason Kahn

December 26, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Caitlin E. Cox

July 02, 2012

Advertisement

Kidney Events High in Older Patients After HF Hospitalization

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

BP Reduction With Renal Denervation Still Evident a Decade On

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Renal Function Gains Seen in CKD Patients After TAVR

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

PCI前肾功能评估的方法选择很重要

Method Chosen to Estimate Pre-PCI Kidney Function Matters

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

Remote Postconditioning Reduces AKI in NSTEMI Patients

Renal Denervation Shows Sustained BP Improvements at 1 Year

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content